BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19398469)

  • 1. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
    Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.
    Gélinas R; Labarthe F; Bouchard B; Mc Duff J; Charron G; Young ME; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1571-80. PubMed ID: 18223187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A; Seymour AM
    Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of the PPAR ligand tetradecylthioacetic acid in type 2 diabetic mice.
    Khalid AM; Hafstad AD; Larsen TS; Severson DL; Boardman N; Hagve M; Berge RK; Aasum E
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2116-22. PubMed ID: 21421822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
    Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.
    Sambandam N; Morabito D; Wagg C; Finck BN; Kelly DP; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H87-95. PubMed ID: 16155108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL.
    Lundåsen T; Pedrelli M; Bjørndal B; Rozell B; Kuiper RV; Burri L; Pavanello C; Turri M; Skorve J; Berge RK; Alexson SEH; Tillander V
    PLoS One; 2020; 15(3):e0229322. PubMed ID: 32176696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity.
    Dewald O; Sharma S; Adrogue J; Salazar R; Duerr GD; Crapo JD; Entman ML; Taegtmeyer H
    Circulation; 2005 Jul; 112(3):407-15. PubMed ID: 16009788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat.
    Strand E; Bjorndal B; Nygard O; Burri L; Berge C; Bohov P; Christensen BJ; Berge K; Wergedahl H; Viste A; Berge RK
    Lipids Health Dis; 2012 Jun; 11():82. PubMed ID: 22738017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
    Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
    Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
    Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced obese mouse hearts tolerate an acute high-fatty acid exposure that also increases ischemic tolerance.
    Boardman NT; Pedersen TM; Rossvoll L; Hafstad AD; Aasum E
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H682-H693. PubMed ID: 32795177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury.
    Lou PH; Zhang L; Lucchinetti E; Heck M; Affolter A; Gandhi M; Kienesberger PC; Hersberger M; Clanachan AS; Zaugg M
    Cardiovasc Res; 2013 Feb; 97(2):251-61. PubMed ID: 23097573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha.
    Banke NH; Wende AR; Leone TC; O'Donnell JM; Abel ED; Kelly DP; Lewandowski ED
    Circ Res; 2010 Jul; 107(2):233-41. PubMed ID: 20522803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.